FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308138317> ?p ?o ?g. }

• W4308138317 endingPage "A846" @default.
• W4308138317 startingPage "A846" @default.
• W4308138317 abstract "Abstract Background The incidence of thyroid cancer in the United States and worldwide has increased 300% over the last three decades.1 Graves’ disease (GD) is the most common cause of hyperthyroidism. GD occurs due to activating antibodies to the TSH receptor. Thyroid-stimulating antibodies can result in intrinsic and genetic factors to favor the tumor growth process.2 Recent studies show that the incidence of thyroid cancer is higher among patients with GD when compared to toxic multinodular goiter.3 The current study compares the outcomes of Differentiated Thyroid Cancer (DTC) in patients with GD with non-GD patients. Objective The aim of the study was to compare demographics, pathology, stage, and prognosis of DTC in patients with GD with non-GD patients. Methods This was a retrospective chart review of 42 patients with a diagnosis of DTC with or without GD. Patients were selected using HERON (Healthcare Enterprise Repository Ontological Narration) software. We compared age at diagnosis, type and size of the tumor, radioactive iodine (RAI) use, and DTC recurrence amongst patients with GD with non-GD patients. We used the Chi-square to test for independence among the categorical variables at a nominal level of 0.05. The comparison of continuous variables was based on the t-test. Results The mean age of patients was 50 years (range 23–86). Out of 42 patients, 29 patients had GD and 13 patients did not have GD. 92% had papillary thyroid cancer and the mean tumor size was 1.3 cm (range 0.09–7.5). 86% of the patients had Stage 1 and 2 DTC. Patients with GD were diagnosed with DTC at a younger age (mean age 46 years) when compared to the patients without GD (mean age 59 years) with a p-value of 0.013. There was no difference in patients with GD in regard to the type of DTC (P = 0.54) and the stage of DTC (p-value 0.139). Both groups of patients had a similar rate of recurrence and RAI use (Table). Conclusion The current study concludes that patients with GD were diagnosed with DTC at an earlier age when compared to patients without GD. The stage of DTC and recurrence rate were similar in the two groups. The study was limited to a small number of patients. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m." @default.
• W4308138317 created "2022-11-08" @default.
• W4308138317 creator A5016992817 @default.
• W4308138317 creator A5034092815 @default.
• W4308138317 creator A5059711515 @default.
• W4308138317 creator A5084800316 @default.
• W4308138317 date "2022-11-01" @default.
• W4308138317 modified "2023-09-25" @default.
• W4308138317 title "PSAT380 Characteristics and prognosis of Differentiated Thyroid Cancer in patients with Graves Disease" @default.
• W4308138317 doi "https://doi.org/10.1210/jendso/bvac150.1749" @default.
• W4308138317 hasPublicationYear "2022" @default.
• W4308138317 type Work @default.
• W4308138317 citedByCount "0" @default.
• W4308138317 crossrefType "journal-article" @default.
• W4308138317 hasAuthorship W4308138317A5016992817 @default.
• W4308138317 hasAuthorship W4308138317A5034092815 @default.
• W4308138317 hasAuthorship W4308138317A5059711515 @default.
• W4308138317 hasAuthorship W4308138317A5084800316 @default.
• W4308138317 hasBestOaLocation W43081383171 @default.
• W4308138317 hasConcept C120665830 @default.
• W4308138317 hasConcept C121332964 @default.
• W4308138317 hasConcept C121608353 @default.
• W4308138317 hasConcept C126322002 @default.
• W4308138317 hasConcept C143998085 @default.
• W4308138317 hasConcept C167135981 @default.
• W4308138317 hasConcept C2779134260 @default.
• W4308138317 hasConcept C2779761222 @default.
• W4308138317 hasConcept C2781461381 @default.
• W4308138317 hasConcept C526584372 @default.
• W4308138317 hasConcept C61511704 @default.
• W4308138317 hasConcept C71924100 @default.
• W4308138317 hasConcept C90924648 @default.
• W4308138317 hasConceptScore W4308138317C120665830 @default.
• W4308138317 hasConceptScore W4308138317C121332964 @default.
• W4308138317 hasConceptScore W4308138317C121608353 @default.
• W4308138317 hasConceptScore W4308138317C126322002 @default.
• W4308138317 hasConceptScore W4308138317C143998085 @default.
• W4308138317 hasConceptScore W4308138317C167135981 @default.
• W4308138317 hasConceptScore W4308138317C2779134260 @default.
• W4308138317 hasConceptScore W4308138317C2779761222 @default.
• W4308138317 hasConceptScore W4308138317C2781461381 @default.
• W4308138317 hasConceptScore W4308138317C526584372 @default.
• W4308138317 hasConceptScore W4308138317C61511704 @default.
• W4308138317 hasConceptScore W4308138317C71924100 @default.
• W4308138317 hasConceptScore W4308138317C90924648 @default.
• W4308138317 hasIssue "Supplement_1" @default.
• W4308138317 hasLocation W43081383171 @default.
• W4308138317 hasLocation W43081383172 @default.
• W4308138317 hasOpenAccess W4308138317 @default.
• W4308138317 hasPrimaryLocation W43081383171 @default.
• W4308138317 hasRelatedWork W1991263625 @default.
• W4308138317 hasRelatedWork W2014028138 @default.
• W4308138317 hasRelatedWork W2075647934 @default.
• W4308138317 hasRelatedWork W2360414982 @default.
• W4308138317 hasRelatedWork W2374149423 @default.
• W4308138317 hasRelatedWork W2792910914 @default.
• W4308138317 hasRelatedWork W2996495160 @default.
• W4308138317 hasRelatedWork W3029474002 @default.
• W4308138317 hasRelatedWork W4226137622 @default.
• W4308138317 hasRelatedWork W50598398 @default.
• W4308138317 hasVolume "6" @default.
• W4308138317 isParatext "false" @default.
• W4308138317 isRetracted "false" @default.
• W4308138317 workType "article" @default.